Chemoinformaics analysis of Bis(1-methyl propenyl) disulfide
| Molecular Weight | 174.334 | nRot | 3 |
| Heavy Atom Molecular Weight | 160.222 | nRig | 2 |
| Exact Molecular Weight | 174.054 | nRing | 0 |
| Solubility: LogS | -4.656 | nHRing | 0 |
| Solubility: LogP | 3.825 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.4951 |
| nHD | 0 | BPOL | 16.5049 |
| QED | 0.588 |
| Synth | 4.359 |
| Natural Product Likeliness | 0.495 |
| NR-PPAR-gamma | 0.365 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -4.358 |
| MDCK | 0.0000185 |
| BBB | 0.895 |
| PPB | 0.942337 |
| VDSS | 2.181 |
| FU | 0.107711 |
| CYP1A2-inh | 0.975 |
| CYP1A2-sub | 0.922 |
| CYP2c19-inh | 0.968 |
| CYP2c19-sub | 0.825 |
| CYP2c9-inh | 0.647 |
| CYP2c9-sub | 0.76 |
| CYP2d6-inh | 0.436 |
| CYP2d6-sub | 0.321 |
| CYP3a4-inh | 0.048 |
| CYP3a4-sub | 0.238 |
| CL | 12.758 |
| T12 | 0.254 |
| hERG | 0.009 |
| Ames | 0.053 |
| ROA | 0.098 |
| SkinSen | 0.961 |
| Carcinogencity | 0.043 |
| EI | 0.994 |
| Respiratory | 0.943 |
| NR-Aromatase | 0.329 |
| Antiviral | No |
| Prediction | 0.946314 |